In addition, ATAD2 inhibition by miR-506 can improve lung adenocarcinoma's sensitivity to cisplatin-based hyperthermia by inhibiting the ATAD2-PI3K-AKT pathway 53. The gene discussed is AKT1; the disease is lung adenocarcinoma.